Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 23, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - November 23, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 21 of 21     Go To Page:

11/22/14 - Dr. Reddy's launches OTC Fexofenadine Hydrochloride 60 g and Pseudoephedrine Hydrochloride 120mg extended-release tablets [EMBIN (Emerging Markets Business Information News]
Dr. Reddy's Laboratories has launched its over-the-counter Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended Release Tablets 60 mg/ 120 mg, a bioequivalent generic version of Allegra-D? 12 Hour Allergy& Congestion, in the U.S. market on November 18, 2014. Dr. Reddy's Laboratories is an integrated global pharmaceutical compan
11/21/14 - Novartis Cosentyx(TM) receives positive CHMP opinion for first-line treatment of moderate-to-severe psoriasis patients
*Cosentyx is recommended as first-line systemic therapy for the treatment of moderate-to-severe plaque psoriasis in adult patients in Europe* In Phase III studies, 70% or more patients achieved clear skin or almost clear skin with secukinumab 300 mg during the first 16 weeks of treatment* Clinical trials consistently showed very high skin clearance
11/21/14 - Orexigen Announces Allowance of New U.S. Patent for Contrave (naltrexone HCl / bupropion HCl extended release)
The patent is expected to expire in March of 2028. Orexigen expects the patent to be listed in the Orange Book maintained by the United States Food and Drug Administration. "A key component of Orexigen's strategy is to strengthen and extend intellectual property protection for Contrave," said Michael Narachi, CEO of Orexigen. Orexigen has also fil
11/21/14 - Uganda Short of 4,500 Pharmacists
Delegates at Monday's Uganda Pharmaceutical Sector Conference in Kampala heard that there are currently barely 600 qualified pharmacists in the country. According to the Pharmaceutical Society of Uganda, one pharmacist serves an average of 100,000 people- way below the World Health Organisation recommendation of one for every 2,000. To redress the.
11/20/14 - Dr. Reddy's Announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended-Release Tablets
Reddy s ANDA is approved by the United States Food& Drug Administration. The Allegra-D 12 Hour brand has U.S. sales of approximately $49.8 million for the latest 52 weeks ending October 6, 2014 for Total US Multi Outlet according to IRI. Reddy s Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing afford
11/20/14 - JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation
Tokyo, Nov 20, 2014 JCI Pharmaceutical Co., Ltd. has announced approval by the US FDA for its MN colloid iodine, a formulation utilizing a world-first technology for converting iodine into a colloidal state to make it absorbable into the body at a large doses. The new formulation converts iodine into a colloid state and further processes it to ma
11/20/14 - Purdue Pharma L.P. Receives FDA Approval for Hysingla? ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties
Purdue Pharma L.P. announced that the U.S. Food and Drug Administration approved Hysingla ER extended-release tablets CII, a once-daily, single-entity medication formulated using Purdue's proprietary extended-release solid oral platform, RESISTEC?. It is the first and only hydrocodone product to be recognized by the FDA as having abuse-deterren
11/19/14 - Axxess Pharma Receives Health Canada Approval to Sell High Potency Omega-3 Fish Oil Supplement Throughout Canada
Axxess Pharma Inc., a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have now received Health Canada approval to sell their high potency Omega-3 fish oil supplement throughout Canada. The Omega-3 fish oil will be sold under the globally recog
11/19/14 - Federal Regulators Announce the Recall of Mayhem Dietary Supplements After Laboratory Testing Reveals Undeclared Drugs, Parker Waichman LLP Comments
Parker Waichman LLP, a national law firm representing patients injured by drugs and medical devices comments on a recall of Mayhem dietary supplements, produced by Chaotic Labz of Atkins, Arkansas. The recall was prompted after a U.S. Food and Drug Administration laboratory analysis revealed the supplement contained undeclared prescription drugs,..
11/19/14 - PURAMED BIOSCIENCE INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-looking statements may also be made in the Company's other reports filed with or furnished to the SEC and in other documents. PuraMed BioScience , Inc. was incorporated in Minnesota on May 9, 2006, as a wholly-owned subsidiary of Wind Energy America, Inc. for the purpose of engaging in the business of developing and marketing non-prescrip
11/18/14 - Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Africa Weekly]
Germany- based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan, which will help it become the world's largest non-prescription medicine group. China's healthcare expenditures are forecast to nearly triple to $1 trillion by 2020,
11/18/14 - Bayer acquires OTC drug firm Dihon for $586 million [China Daily: Hong Kong Edition]
Germany- based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmac eu tical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan, which will help it become the world's largest non-prescription medicine group. China's healthcare expenditures are forecast to nearly triple to $1 trillion by 202
11/18/14 - Bayer acquires OTC drug firm Dihon for $586 million [China Daily: US Edition]
Germany- based drugmaker Bayer AG said it has completed the acquisition of privately held Dihon Pharmaceutical Group Co Ltd in Kunming, capital of Yunnan province, for 3.6 billion yuan, which will help it become the world's largest non-prescription medicine group. China's healthcare expenditures are forecast to nearly triple to $1 trillion by 2020,
11/17/14 - Actavis To Acquire Allergan In $66 Bln Deal
DUBLIN- Specialty pharmaceutical company Actavis plc agreed Monday to acquire botox maker Allergan, Inc. in a cash and stock deal valued at about $219 per share or $66 billion. The deal will enable Allergan to fend off a hostile takeover bid from Canadian drug maker Valeant Pharmaceuticals, Inc., which is supported in its bid by activist investor W
11/17/14 - BASF welcomes the passage of the Sunscreen Innovation Act by the House of Representatives; House of Representatives approves bill to reform process for approving new sunscreen ingredients
"As a member of the Public Access to Sun Screens Coalition, BASF highly welcomes the Sunscreen Innovation Act. Passage of the bill represents a significant step towards ensuring the timely review of new sun protection ingredients by the FDA, that will ultimately provide US consumers with a wider array of safe and effective sunscreen products, "said
11/17/14 - Jeffrey D. DeCarlo Law, P.A., Comments On Study Claiming Dangerous Prescription Drug Ingredients Found In Dietary Supplements
Ingredients for potentially dangerous prescription drugs have been found in over-the-counter dietary supplements, even though these ingredients were recalled for safety reasons years ago, according to a recent study that came as no surprise to drug injury lawyer Jeffrey D. DeCarlo of the Law Office of Jeffrey D. DeCarlo, P.A.. DeCarlo made his comm
11/17/14 - New retrospective data showed empagliflozin reduced A1C, body weight and markers of abdominal fat in adults with type 2 diabetes
RIDGEFIELD, Conn. and INDIANAPOLIS, Nov. 17, 2014/ PRNewswire/ Empagliflozin tablets reduced hemoglobin A1C, body weight and several markers of abdominal fat in adults with type 2 diabetes, according to a new retrospective analysis of clinical trial data presented on behalf of Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company a
11/17/14 - Perrigo Company plc Announces Quarterly Dividend
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on December 16, 2014 to shareholders of record on November 28, 2014. >From its beginnings as a packager of generic home remedies in 1887, Perrigo Company plc, headquarter
11/17/14 - Perrigo Reinitiates Shipments Of Guaifenesin Extended-Release 600mg Tablets, The Store Brand Equivalent To Mucinex 600mg Extended-Release Tablets
By a News Reporter-Staff News Editor at Pharma Business Week Perrigo Company plc announced that it has reinitiated shipments of Guaifenesin 600 mg Extended-Release tablets to its retail and wholesale customers in the United States. Perrigo's Chairman and CEO Joseph C. Papa stated, "This re-launch is representative of the Perrigo team's abilities
11/17/14 - Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President of Medical Affairs
Purdue Pharma L.P. today announced that Gail Cawkwell, MD, PhD, former Vice President in the Medicines Development Group at Pfizer, has joined the company as Vice President of Medical Affairs. "Gail brings to Purdue strong credentials and broad and relevant skills in all aspects of Medical Affairs, including drug development and regulatory and c
11/17/14 - US FDA chief going to China for drugs review [China Daily: Hong Kong Edition]
The head of the US Food and Drug Administration is going to China this week to complete agreements on inspection and regulatory reviews for drugs with seventh-largest provider of pharmaceuticals to the United States. "I think we are in a productive place to share information and we have rapidly expanded our offices in China," she told China Daily
Articles(s): 1 - 21 of 21     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Newest and Most Current Medications in the Treatment of Diabetes
This lesson is supported by:
RxSchool
HIV & AIDS Testing & Reporting Guidelines
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415